13F-HR filed by Soleus Capital Management, L.P.
Soleus Capital Management, L.P. filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 73 holding rows worth $901,249,517.
- Accession
- 0001802630-24-000003
- Filer
- CIK 1802630
- Filed
- 2024-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 73 entries on the cover page, a total value of $901,249,517 stated on the cover page (in dollars after the unit check, H1), rows summing to $901,249,517 with VALUE read as dollars as filed, 13F file number 028-20043. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 5,564,440 | $58,092,754 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 249,449 | $54,851,341 | dollars as filed | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 1,278,540 | $47,382,692 | dollars as filed | |
| RAYZEBIO INC | 75525N107 | COM | 746,622 | $46,417,490 | dollars as filed | |
| EDAP TMS S A | 268311107 | SPONSORED ADR | 7,226,341 | $38,155,080 | dollars as filed | |
| ORGANOGENESIS HOLDINGS INC | 68621F102 | COMMON STOCK | 8,963,000 | $36,658,670 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 73,706 | $33,743,344 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 2,179,481 | $31,755,038 | dollars as filed | |
| IRADIMED CORP | 46266A109 | COMMON STOCK | 643,206 | $30,532,989 | dollars as filed | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 4,327,622 | $28,562,305 | dollars as filed | |
| Surmodics Inc | 868873100 | Common Stock | 771,700 | $28,051,295 | dollars as filed | |
| HCA Healthcare Inc | 40412C101 | COM | 101,500 | $27,474,020 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 415,450 | $26,090,260 | dollars as filed | |
| NEUROPACE INC | 641288105 | COMMON STOCK | 2,433,168 | $25,085,962 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 322,888 | $23,761,328 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 9,777,419 | $22,585,838 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 564,700 | $20,092,026 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 79,400 | $19,972,276 | dollars as filed | |
| AXOGEN INC | 05463X106 | COM | 2,595,815 | $17,729,416 | dollars as filed | |
| ATRICURE INC | 04963C209 | COM | 392,195 | $13,997,440 | dollars as filed | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 9,442,579 | $13,691,740 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 317,050 | $13,357,317 | dollars as filed | |
| TREACE MED CONCEPTS INC | 89455T109 | COM | 1,014,005 | $12,928,564 | dollars as filed | |
| SMITH & NEPHEW PLC SPDN ADR NEW | 83175M205 | ADR | 470,198 | $12,827,001 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 1,425,634 | $11,604,661 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 514,000 | $11,107,540 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 650,000 | $11,102,000 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 1,835,996 | $10,373,377 | dollars as filed | |
| BIOATLA INC | 09077B104 | COM | 4,065,197 | $10,000,385 | dollars as filed | |
| TRANSMEDICS GROUP INC | 89377M109 | COM | 123,112 | $9,717,230 | dollars as filed | |
| HARPOON THERAPEUTICS INC | 41358P205 | COM | 820,638 | $9,330,654 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 159,000 | $8,824,500 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 964,550 | $8,439,813 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 847,145 | $8,386,736 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 302,577 | $8,320,868 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 436,200 | $8,117,682 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871103 | COM | 9,870,980 | $7,788,203 | dollars as filed | |
| THERATECHNOLOGIES INC | 88338H704 | COM | 4,801,376 | $7,778,229 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 252,000 | $7,227,360 | dollars as filed | |
| SI BONE INC | 825704109 | COM | 341,818 | $7,174,760 | dollars as filed | |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 537,000 | $6,588,990 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 217,396 | $6,097,958 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 167,100 | $5,178,429 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 40,000 | $4,962,400 | dollars as filed | |
| CVS Health Corporation | 126650100 | COM | 59,500 | $4,698,120 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 555,000 | $4,512,150 | dollars as filed | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 301,000 | $4,493,930 | dollars as filed | |
| INSPIREMD INC | 45779A846 | COM | 1,378,128 | $3,872,540 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 138,000 | $3,005,640 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 130,000 | $2,789,800 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 58,000 | $2,671,480 | dollars as filed | |
| HOLOGIC INC | 436440101 | COM | 34,000 | $2,429,300 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 515,400 | $2,339,916 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 14,800 | $2,293,556 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 83,000 | $1,903,190 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 95,000 | $1,717,600 | dollars as filed | |
| VYNE THERAPEUTICS INC | 92941V308 | COM | 703,868 | $1,640,012 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 460,793 | $1,543,657 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 143,000 | $1,475,760 | dollars as filed | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 157,182 | $1,071,981 | dollars as filed | |
| AVITA THERAPEUTICS, INC. | 05380C102 | COM | 75,000 | $1,029,000 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 35,000 | $977,900 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 45,748 | $926,854 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 5,300 | $737,972 | dollars as filed | |
| INHIBRX INC | 45720L107 | COM | 15,000 | $570,000 | dollars as filed | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 26,000 | $561,080 | dollars as filed | |
| SKINHEALTH SYSTEMS INC | 88331L108 | COM CL A | 155,000 | $482,050 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 300,000 | $450,000 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 13,050 | $386,933 | dollars as filed | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 425,000 | $319,940 | dollars as filed | |
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 60,000 | $165,000 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 62,083 | $145,895 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 10,000 | $120,300 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001802630-24-000003 | this filing | 2024-02-14 | acceptance time not in the bulk data set |